Clinical Trials on Metastatic Castration-sensitive Prostate Cancer in Hong Kong

Total 214 results

CCTU

Recruiting

SRAM study_Postate Cancer

Advanced Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Active, not recruiting

Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Terminated

High-intensity Focused Ultrasound Study

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Completed

Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node Dissection

Prostate Cancer

Hong Kong
The University of Hong Kong

Unknown

Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men

Prostatic Hyperplasia | Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Not yet recruiting

To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

The Performance of MRI Prostate in Men With Different Prostate Health Index (Phi) Values

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy (SMART)

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Active, not recruiting

Microwave Needle Thermoablation for Treatment of Localized Prostate Cancer

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Not yet recruiting

Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Withdrawn

Spermine Measuring Device Evaluation Protocol

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Completed

Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese Patients

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT (ADTCV care)

Prostate Cancer | Cardiovascular Risk

Hong Kong
Chinese University of Hong Kong

Recruiting

Effectiveness of Cryotherapy Study for Prostate Cancer

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Withdrawn

A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

MRI Prostate for Chinese Men Being Screened for Prostate Cancer

MRI | Prostate Cancer | PSA

Hong Kong
Chinese University of Hong Kong

Recruiting

Comparing Water Vapour Thermal Therapy (Rezūm) and TURP

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

Hong Kong Prostate Cancer Study Group Database

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Active, not recruiting

Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) (READT)

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

To Identify Potential New Urine Markers for the Screening of Prostate Cancer

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Completed

The Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate Cancer

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Completed

To Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer Patients

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong

Obesity | Breast Cancer | Colorectal Cancer | Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Recruiting

A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer

Prostate Cancer

Hong Kong
Chinese University of Hong Kong
Janssen, LP

Terminated

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

Prostate Cancer

Hong Kong
The University of Hong Kong

Unknown

Circulating Tumor Cells in mCRC for Liver Resection

Metastatic Colorectal Cancer | Circulating Tumor Cell

Hong Kong
Chinese University of Hong Kong
Ipsen

Completed

Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment

Prostate Cancer

Hong Kong
Chinese University of Hong Kong

Completed

Factors Affecting Androgen Deprivation Therapy Choice in Prostate Cancer Patients

Prostate Cancer

Hong Kong
The University of Hong Kong
Research Grants Council, Hong Kong

Recruiting

Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches

Fear of Cancer Progression | Metacognition-based Intervention | Supportive-expressive Based Intervention | Psychooncology | Advanced or Metastatic Cancer

Hong Kong
Chinese University of Hong Kong

Completed

Cetuximab Rechallenge Study

Metastatic Colorectal Cancer

Hong Kong
Chinese University of Hong Kong

Completed

Intermittent Versus Continuous Tarceva Study

Metastatic Colorectal Cancer

Hong Kong
PROCEPT BioRobotics

Recruiting

PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs

Benign Prostatic Hyperplasia | Localized Prostate Cancer

Lebanon, Hong Kong, United States
Chinese University of Hong Kong

Completed

PET-CT and Circulating Tumor Cells in Colorectal Cancer

Colorectal Cancer | Metastasis

Hong Kong
AstraZeneca

Recruiting

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents (EvoPAR-PR01)

Metastatic Castration-Sensitive Prostate Cancer

United States, Canada, Spain, United Kingdom, Italy, Australia, Korea, Republic of, Belgium, Germany, Japan, Peru, France, China, India, Taiwan, Thailand, Austria, Brazil, Turkey, Malaysia, Finland, Netherlands, Chile, Hungary, Poland, Sw...
Hong Kong Children's Hospital
The University of Hong Kong

Recruiting

Propofol vs Sevo for Paediatric Tumor Surgery

Carcinoma | Cancer | Solid Tumor | Malignancy

Hong Kong
Chinese University of Hong Kong

Recruiting

EUS Guided HVA and PVA for Circulating Tumor DNA in Patients

Gastrointestinal Cancer | Circulating Tumor Cell

Hong Kong
The University of Hong Kong
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...

Completed

Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC

Nasopharyngeal Carcinoma | Metastatic Cancer | Recurrent Carcinoma | Non-keratinizing Carinoma

Hong Kong
Chinese University of Hong Kong
Department of Electronic and computer engineering, HKUST; Department of clinical... and other collaborators

Recruiting

Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment

Breast Cancer

Hong Kong
Medtronic - MITG

Completed

Clinical Description of a Bronchoscopic Approach to Ablate Lung Nodules Using the Emprint™ Ablation Catheter (NAVABLATE)

Cancer, Lung | Cancer, Metastatic to Lung

Hong Kong, United Kingdom
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

Metastatic Cancer | Liver Cancer

United States, China
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM) (A-DREAM)

Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate Carcinoma

United States
Cancer Therapeutics Research Group
National Cancer Institute (NCI)

Completed

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Prostate Cancer

Australia, Singapore, Hong Kong
Astellas Pharma Inc

Active, not recruiting

An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants

Progressive Metastatic Prostate Cancer

China, Hong Kong, Korea, Republic of, Taiwan
Amgen

Completed

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

United States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
Merck Sharp & Dohme LLC
Orion Corporation, Orion Pharma

Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Prostatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)

Germany, United States, Puerto Rico, Israel, Australia, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom
Bayer

Active, not recruiting

Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer (REASSURE)

Metastatic Castration-resistant Prostate Cancer

United States, Austria, Czechia, Israel, Italy, Germany, United Kingdom, France, Mexico, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Denmark, Sweden, Argentina, Portugal
SWOG Cancer Research Network
National Cancer Institute (NCI)

Recruiting

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostatic Adenocarcinoma | Castration Levels of Testosterone

United States, Switzerland, Mexico, Chile, Colombia

Clinical Trials on Metastatic Castration-sensitive Prostate Cancer in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations